Chondroitin sulfate API
Biologically derived active ingredient for osteoarthritis and joint discomfort
Chondroitin sulfate is an important structural component of the cartilage and other connective tissues in the body, such as tendons, ligaments, skin, and also blood vessels.
Bioiberica Chondroitin sulphate API is a high quality ingredient for the development of finished pharmaceutical formulations targeting osteoarthritis and joint discomfort.
What is chondroitin sulfate?
Quality, effectiveness and complete safety: Our chondroitin sulfate API is a powerful, biologically derived solution for joint health and mobility, shown to lessen discomfort and boost patient quality of life.
Fully compliant with US and EU Pharmacopoeias and manufactured in Europe according to strict GMP quality standards, our pharmaceutical grade chondroitin sulfate API is recognised as a symptomatic slow-acting drug for osteoarthritis (SYSADOA) that effectively reduces joint pain. We have two grades available: chondroitin sulfate for non-sterile dosage forms and chondroitin sulfate for sterile dosage forms.
Chondroitin sulfate for osteoarthritis: Supporting healthy joints
Chondroitin sulfate is a sulfated glycosaminoglycan found in the extracellular matrix (ECM) of cartilage – a flexible connective tissue that keeps joint movement fluid and flexible. As we age, our cartilage can begin to wear down, resulting in lowered levels of naturally-occurring chondroitin sulfate and the onset of degenerative joint disorders that cause pain, stiffness, and loss of articular function.
With our high-quality chondroitin sulfate API of both bovine and porcine origin, Bioiberica is your trusted partner for tackling mobility challenges – however they present. Beyond our standard-setting ingredients, we offer the technical support and regulatory expertise pharmaceutical manufacturers need to bring their products to market faster and achieve enduring success.
Pioneering pharmaceutical excellence
With full visibility of our vertically integrated supply chain and industry-leading production standards, we deliver quality-assured health and nutrition solutions that are as reliable, as they are powerful.
Regulatory dossiers submitted to key health authorities and referenced in different drug applications:
- EDQM: CEP 2023-243 (double CEP for bovine chondroitin sulfate)
- CEP 2024-106 (chemical CEP for porcine chondroitin sulfate)
- CEP 2001-063 (TSE CEP for bovine chondroitin sulfate) • EAEU MoH • Russian MoH (Normative Documentation)
- Taiwan FDA
- Korea FDA
- Japan MHLW (Accreditation of Foreign Manufacturer)
Product information sheet
Discover more about our chondroitin sulfate API and how it can help you develop safe and effective mobility solutions the pharma market needs.
Do you have any product-specific questions?
Need more information or want to order a product sample? Submit your queries via the form below and our experts will respond with the insights you need.